Institute of Biomedicine - News

A new study suggests that skin fibroblasts from frontotemporal dementia patients may be useful in investigating underlying disease mechanisms as well as in biomarker and drug research.

Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner.

Researchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a therapeutic target in early Alzheimer’s disease.

The Academy of Finland’s Research Council for Biosciences, Health and the Environment announced yesterday 24 new Academy Research Fellow posts and 33 new Postdoctoral Researcher posts.

Researchers can now investigate individual leukaemia cells to find out what makes them resistant to treatment. “Single-cell technologies provide an immense amount of new information on the diversity of cancer cells,” says Merja Heinäniemi, Professor of Computational Biomedicine.

Can vitamin D supplementation prevent cancer, diabetes or COVID-19? Recent research has yielded both hope, disappointments and new questions.

The aim of the new national competence network is to increase cooperation between universities, hospitals, and the business worlds and to make Finnish neuroscience know-how visible internationally.

Increasing vigorous physical activity reduces cardiometabolic risk factors already in primary school children, according to the doctoral thesis of Juuso Väistö, MHSc.

A new review reveals insights into the potential drivers of a currently incurable eye disease, age-related macular degeneration (AMD).